PPARD and cancer: PGI2, as a precursor of protumorigenic metabolites, not only promotes cancer growth by activating peroxisome proliferator-activated receptor δ (PPARδ) and increases the expression levels of the proangiogenic factor vascular endothelial growth factor [42] but also seems to act primarily on TAMs, which promote all aspects of cancer growth and progression [43].